ROCHE HLDGS AG - CH0012032048 (Stock)
Berlin
Price | Diff.% | Date & Time | Bid volume | Bid | Ask | Ask volume |
---|---|---|---|---|---|---|
276,00 EUR
![]() |
-1,4286% | 22.05.2025 16:40 | 80,00 | 274,00 | 278,00 | 80,00 |
Contact | |
---|---|
|
Roche Holding AG Grenzacherstrasse 124 4058, Basel, CH |
Phone | +41-61-688-11-11 |
Fax | + |
Internet | http://www.roche.com |
IR Contact/PR Contact | Karl Mahler/- |
Symbol | ROCH |
End of financial year | 31.12.2025 |
Issued capital | 225.407.830.412,00 EUR |
Shareholders | |
---|---|
Hoffmann Family | 64,97% |
Freefloat | 20,08% |
Maja Oeri | 7,58% |
Canada Pension Plan Investment Board | 1,80% |
UBS Asset Management Switzerland AG | 1,29% |
The Vanguard Group, Inc. | 1,16% |
APG Asset Management NV | 1,12% |
BlackRock Fund Advisors | 0,61% |
Janus Henderson Investors UK Ltd. | 0,55% |
Zürcher Kantonalbank (Investment Management) | 0,52% |
Geode Capital Management LLC | 0,31% |
Board | |
---|---|
André Hoffmann | Member of the administrative board |
Dr. Ulf Mark Schneider | Member of the administrative board |
Dr. Richard Lifton | Member of the administrative board |
Dr. Patrick Frost | Member of the administrative board |
Dr. Joerg Duschmale | Member of the administrative board |
Anita Hauser | Member of the administrative board |
Dr. Claudia Dyckerhoff | Member of the administrative board |
Dr. Akiko Iwasaki | Member of the administrative board |
Dr. Jemilah Mahmood | Member of the administrative board |
Dr. Severin Schwan | Chairman of the administrative boar |
Dr. Thomas Schinecker | Chairman of Managing Board |
Teresa Graham | Member of Executive Committee |
Silke Hörnstein | Member of Executive Committee |
Matt Sause | Member of Executive Committee |
Cristina A. Wilbur | Member of Executive Committee |
Claudia Böckstiegel | Member of Executive Committee |
Boris L. Zaïtra | Member of Executive Committee |
Barbara Schädler | Member of Executive Committee |
Dr. Levi Garraway | Member of Executive Committee |
Dr. Dr. Hans Clevers | Member of Executive Committee |
Dr. Alan Hippe | Member of Executive Committee |
Dr. Aviv Regev | Member of Executive Committee |
Activity Description |
---|
Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. |